Sorted By:

Relevance


Rheumatoid Arthritis Treatments Continue to Demonstrate Increased Value through Additional Research

PhRMA  |  Fact Sheet

This fact sheet includes new data that reveals broader benefits than anticipated at the time of FDA approval for RA treatments
https://www.phrma.org/fact-sheet/rheumatoid-arthritis-treatments-continue-to-demonstrate-increased-value-through-additional-research

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

PhRMA  |  Blog Post

Independent providers may have less negotiating leverage, such as those in small practices or rural areas, and may pay above ASP for some products.
http://catalyst.phrma.org/medicare-monday-did-you-know-medicare-part-b-uses-a-market-based-system-to-pay-for-medicines

Who Has a Seat at ICER's Table?

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/who-has-a-seat-at-icer-s-table

India and Intellectual Property

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested approximately $550 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone.
https://www.phrma.org/press-release/india-and-intellectual-property

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

Disease modifying therapies for the management of multiple sclerosis save money and improve patient outcomes

PhRMA  |  Blog Post

The study found that DMT therapy was associated with a reduction in relapse episodes and health care resource use during the year before and after the index date.
http://catalyst.phrma.org/disease-modifying-therapies-for-the-management-of-multiple-sclerosis-save-money-and-improve-patient-outcomes

Ohio

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/ohio

New Ads from America’s Biopharmaceutical Companies Feature Patients and Unsung Heroes Behind Cutting-Edge Scientific Advances

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/new-ads-from-america-s-biopharmaceutical-companies-feature-patients-and-unsung-heroes-behind-cutting-edge-scientific-advances

340B Spotlight: Myth vs. Fact

PhRMA  |  Graphic

Unfortunately, over the years a lot of myths have been perpetuated about how the program works and who it benefits.
https://www.phrma.org/graphic/340b-spotlight-myth-vs-fact

RxE HCV in Indiana

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-indiana

ICYMI: Avalere and FasterCures develop new value framework from patient perspective

PhRMA  |  Blog Post

We are proud to be a part of the PPVF initiative to support the development of well-designed tools to empower health care decision-making and ensure the right treatments reach the right patients at the right time.
http://catalyst.phrma.org/icymi-avalere-and-fastercures-develop-new-value-framework-from-patient-perspective

340B Spotlight: ICYMI – AJC looks at how some Georgia hospitals are profiting off 340B

PhRMA  |  Blog Post

In order to maintain the long-term stability of the program, it is important to fully review and update 340B.
http://catalyst.phrma.org/340b-spotlight-icymi-ajc-looks-at-how-some-georgia-hospitals-are-profiting-off-340b

Compulsory licensing: A misused and abused international trade law

PhRMA  |  Blog Post

Routine use of compulsory licenses is chipping away at this protection, and endanger U.S. biopharmaceutical innovators, as well as the economic output and jobs they support.
http://catalyst.phrma.org/compulsory-licensing-a-misused-and-abused-international-trade-law

RxE HCV in California

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-california

RxE HCV in Pennsylvania

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-pennsylvania

Medicines in Development for Heart Disease & Stroke 2015

PhRMA  |  Report

Heart disease has been the leading cause of death in the United States since 1921, but these numbers are declining.
https://www.phrma.org/report/medicines-in-development-for-heart-disease-and-stroke-2015-report

Senior Manager of Application Support and Power BI

PhRMA  |  PhRMA Career

Connect with PhRMAFor information on how innovative medicines save lives, please visit:  www.PhRMA.org .innovation.org/?
https://www.phrma.org

First Transplant from HIV-Positive Donor Performed in U.S.

From Hope To Cures  |  From Our Network

“We are very thankful to Congress, the President and the entire transplant community for letting us use organs from HIV-positive patients to save lives instead of throwing them away, as we had to do for so many years,” said Dr.
http://www.fromhopetocures.org/first-transplant-from-hiv-positive-donor-performed-in-u-s

PhRMA Statement Following Meeting With President Trump

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone. 
https://www.phrma.org/press-release/phrma-statement-following-meeting-with-president-trump

How Medicine Purchased at a Canadian Internet Pharmacy Could Actually Be Fake

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/how-medicine-purchased-at-a-canadian-internet-pharmacy-could-actually-be-fake

Enforcing unmet trade obligations protects U.S. innovation

PhRMA  |  Blog Post

Early resolution of patent disputes helps prevent patent-infringing products from prematurely entering the market.
http://catalyst.phrma.org/enforcing-unmet-trade-obligations-protects-us-innovation

I’m Not Average – Matt Ellefson May Have Cancer, But Cancer Doesn’t Have Him

PhRMA  |  Video

In this video he shares his inspirational story of defying the odds and managing his disease to lead a happy and active life because of the progress made in cancer research.
https://www.phrma.org/video/i-m-not-average-matt-ellefson-may-have-cancer-but-cancer-doesn-t-have-him

The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research

PhRMA  |  Blog Post

The biopharmaceutical industry is committed to continuing research efforts to enhance treatments, find a cure and provide hope to millions of patients and their families worldwide.
http://catalyst.phrma.org/the-war-on-alzheimers-progress-and-challenges-of-biopharmaceutical-research

Medicare Monday: Have you heard of CMMI?

PhRMA  |  Blog Post

Learn more about CMMI and the importance of safeguarding CMMI on our new webpage.
http://catalyst.phrma.org/medicare-monday-have-you-heard-of-cmmi

How New Drugs Helping Millions Of Americans Live Longer Are Also Making Them Go Broke

Access Better Coverage  |  From Our Network

” Those working with HIV positive people say they have seen this phenomenon in action.
http://www.accessbettercoverage.org/social-news/how-new-drugs-helping-millions-of-americans-live-longer-are-also-making-them-go-broke

You have reviewed the first 175 results out of 2653. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next